Biocon Ltd. — Capital/Financing Update 2025

Apr 4, 2025

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T: 91 80 2808 2808 F: 91 80 2852 3423 CIN : L24234KA1978PLC003417 www.biocon.com

BIO/SECL/SP/2025-26/05

April 04, 2025

To,The SecretaryBSE LimitedDepartment of Corporate ServicesPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001	To,The SecretaryNational Stock Exchange of India LimitedCorporate Communication DepartmentExchange Plaza, Bandra Kurla ComplexMumbai – 400 050
Scrip Code – 532523	Scrip Symbol - Biocon

Dear Sir/Madam,

Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors at its meeting held today, i.e. on Friday, April 04, 2025, has approved issuance of Commercial Papers up to an amount not exceeding Rs. 600 Crores in one or more tranches on private placement basis.

The above-mentioned information will also be available on the website of the Company at www.biocon.com.

Further, the Board Meeting commenced at 07:30 PM and concluded at 08:00 PM.

Kindly take the above information on record and acknowledge.

Thanking You,

For Biocon Limited

Digitally signed MAYANK by MAYANK VERMA VERMA Date: 2025.04.04 20:47:37 +05'30' _________________

==> picture [73 x 76] intentionally omitted <==

Mayank Verma Company Secretary and Compliance Officer Membership No.: ACS 18776